Well, I hope you are right.
It sounds great to investors to hear a boss say the company is in talks about deals but Nina's language suggests they are not taking the first 'frogs' they encounter and are standing their ground to get the best terms possible which is good because it displays confidence in their drug.
Just my opinion.
Ann: Investor Presentation, page-149
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $217.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.0¢ | $444.0K | 1.151M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 7392 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |